AR012989A1 - Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa. - Google Patents
Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa.Info
- Publication number
- AR012989A1 AR012989A1 ARP980102859A ARP980102859A AR012989A1 AR 012989 A1 AR012989 A1 AR 012989A1 AR P980102859 A ARP980102859 A AR P980102859A AR P980102859 A ARP980102859 A AR P980102859A AR 012989 A1 AR012989 A1 AR 012989A1
- Authority
- AR
- Argentina
- Prior art keywords
- novel sulfonamide
- farnesil
- protein transferase
- sulfonamide inhibitors
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87705097A | 1997-06-17 | 1997-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012989A1 true AR012989A1 (es) | 2000-11-22 |
Family
ID=25369146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102859A AR012989A1 (es) | 1997-06-17 | 1998-06-16 | Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0989980A1 (zh) |
| JP (1) | JP2002507192A (zh) |
| KR (1) | KR20010013826A (zh) |
| CN (1) | CN1267290A (zh) |
| AR (1) | AR012989A1 (zh) |
| AU (1) | AU8253698A (zh) |
| CA (1) | CA2293358C (zh) |
| CO (1) | CO4940475A1 (zh) |
| HU (1) | HUP0004627A2 (zh) |
| IL (1) | IL133393A0 (zh) |
| NZ (1) | NZ501619A (zh) |
| PE (1) | PE86199A1 (zh) |
| WO (1) | WO1998057949A1 (zh) |
| ZA (1) | ZA985218B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6689789B2 (en) | 1997-06-17 | 2004-02-10 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
| US7517884B2 (en) | 1998-03-30 | 2009-04-14 | Kalypsys Inc. | Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| US7494999B2 (en) | 2004-10-29 | 2009-02-24 | Kalypsys, Inc | Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| PE20020635A1 (es) * | 2000-11-29 | 2002-07-11 | Schering Corp | Compuestos triciclicos como inhibidores de la farnesil transferasa |
| NZ566831A (en) | 2005-10-25 | 2011-09-30 | Kalypsys Inc | Salts of modulators of PPAR and methods of treating metabolic disorders |
| WO2008091863A1 (en) | 2007-01-23 | 2008-07-31 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
| US9796717B2 (en) * | 2013-02-19 | 2017-10-24 | Icahn School Of Medicine At Mount Sinai | Tricyclic heterocycles as anticancer agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2164717T3 (es) * | 1993-10-15 | 2002-03-01 | Schering Corp | Compuestos triciclicos de sulfonamida utiles para inhibir la funcion de la proteina-g y para el tratamiento de enfermedades proliferativas. |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| IL117797A0 (en) * | 1995-04-07 | 1996-08-04 | Pharmacopeia Inc | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
-
1998
- 1998-06-15 WO PCT/US1998/011508 patent/WO1998057949A1/en not_active Application Discontinuation
- 1998-06-15 PE PE1998000508A patent/PE86199A1/es not_active Application Discontinuation
- 1998-06-15 IL IL13339398A patent/IL133393A0/xx unknown
- 1998-06-15 CA CA002293358A patent/CA2293358C/en not_active Expired - Fee Related
- 1998-06-15 NZ NZ501619A patent/NZ501619A/en unknown
- 1998-06-15 JP JP54752198A patent/JP2002507192A/ja active Pending
- 1998-06-15 EP EP98932718A patent/EP0989980A1/en not_active Withdrawn
- 1998-06-15 HU HU0004627A patent/HUP0004627A2/hu unknown
- 1998-06-15 AU AU82536/98A patent/AU8253698A/en not_active Abandoned
- 1998-06-15 CN CN98808186A patent/CN1267290A/zh active Pending
- 1998-06-15 KR KR1019997011846A patent/KR20010013826A/ko not_active Application Discontinuation
- 1998-06-15 ZA ZA985218A patent/ZA985218B/xx unknown
- 1998-06-16 CO CO98034142A patent/CO4940475A1/es unknown
- 1998-06-16 AR ARP980102859A patent/AR012989A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO4940475A1 (es) | 2000-07-24 |
| PE86199A1 (es) | 1999-09-24 |
| HUP0004627A2 (hu) | 2001-10-28 |
| EP0989980A1 (en) | 2000-04-05 |
| CA2293358C (en) | 2008-08-05 |
| ZA985218B (en) | 1998-12-15 |
| IL133393A0 (en) | 2001-04-30 |
| CA2293358A1 (en) | 1998-12-23 |
| KR20010013826A (ko) | 2001-02-26 |
| NZ501619A (en) | 2002-02-01 |
| JP2002507192A (ja) | 2002-03-05 |
| WO1998057949A1 (en) | 1998-12-23 |
| CN1267290A (zh) | 2000-09-20 |
| AU8253698A (en) | 1999-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tanaka et al. | Hydrophobic regions function in calmodulin-enzyme (s) interactions. | |
| Chesney et al. | Effect of platelet-activating factor (PAF) on human platelets | |
| BR9713465A (pt) | Inibidores metalotprotease de amina cìclica sibstituìda | |
| Naghshineh et al. | Activation of adipocyte adenylate cyclase by protein kinase C. | |
| MX9206008A (es) | Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida. | |
| BR9814340A (pt) | Derivados de indol como inibidores de fator xa | |
| RU94015838A (ru) | Производные бензофуранил- или бензотиофенилалкан-карбоновой кислоты, смесь их изомеров или отдельные изомеры и их соли | |
| RU94031747A (ru) | Соединения и способы лечения | |
| BR9809342A (pt) | Composto, composição farmacêutica, e, uso do composto | |
| Fenton et al. | Biogenesis of the mitochondrial enzyme methylmalonyl-CoA mutase. Synthesis and processing of a precursor in a cell-free system and in cultured cells. | |
| Malemud et al. | Identification of neutral proteases in human neutrophil granules that degrade articular cartilage proteoglycan | |
| BR0112337A (pt) | Derivados de fosfolipìdeos de ácido valpróico e suas misturas | |
| AR012989A1 (es) | Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa. | |
| Hope et al. | Secretory phospholipase A 2 inhibitors and calmodulin antagonists as inhibitors of cytosolic phospholipase A 2 | |
| CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| AR009809A1 (es) | Derivados de 10,13,15-trioxatriciclo[9.2.1(9.6)]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos | |
| ES2150461T3 (es) | Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes. | |
| Keraly et al. | Inhibition by ticlopidine of PAF-acether-induced in vitro aggregation of rabbit and human platelets | |
| BR0308601A (pt) | inibidores de carboxipeptidase b de plasma | |
| BR9816072A (pt) | Composição clareadora da pele contendo um composto de ácido ascórbico | |
| ATE299140T1 (de) | Farnesyl-protein transferase inhibitoren | |
| NO20003880L (no) | Transfekterende midler som er sensitive overfor reduserende betingelser, farmasøytiske preparater inneholdende disse samt deres anvendelser | |
| ES2054904T3 (es) | Procedimiento para la preparacion de peptidos con actividad inhibidora de sistemas enzimaticos. | |
| ECSP982530A (es) | Novedosos inhibidores de sulfonamida de la farnesil - protein transferasa | |
| ES2164454T3 (es) | Nuevos compuestos derivados de acido alquilendiamina di o tri-acetico, su procedimiento de preparacion, su utilizacion en composiciones cosmeticas y farmaceuticas y composiciones que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |